Track topics on Twitter Track topics that are important to you
Regeneron Pharmaceuticals Inc reported a 47 percent jump in quarterly profit on Wednesday on higher demand for its flagship eye treatment Eylea. The U.S. biotechnology company said net income rose to $388.3 million, or $3.32 per share, in the third quarter ended Sept.
Original Article: Drugmaker Regeneron's quarterly profit surges 47 pctNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...